International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 69-72, July 2010

In vitro activity of oritavancin against community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA)

St John Hospital and Medical Center and Wayne State University School of Medicine, Detroit, MI, USA

Received 9 November 2009; accepted 26 February 2010. published online 22 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0924-8579(10)00116-0

doi:10.1016/j.ijantimicag.2010.02.023

International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 69-72, July 2010

Article Tools